CCRB Logo

Modification History

CUHK_CCT00098

A Randomized, Open-labebeled, Parallel, Comparative Study of the Efficacy and Tolerability of Rosuvastatin in LDL-C Reduction Using Different Dosing Regimes of 5mg Daily, 10mg Daily and 10mg Alternate day in Hong Kong Chinese Type 2 Diabetic Patients.

2006-03-02

Update Date Recruitment Status Modified By  
2013-09-11 Complete Administrator Detail
2013-09-11 Complete Administrator Detail
2013-01-11 Complete Registry User Detail
2012-08-31 Unknown Administrator Detail
2011-04-18 Unknown Administrator Detail
2011-02-08 Recruiting Administrator Detail
2009-11-19 Recruiting Administrator Detail
2006-03-02 Recruiting Registry User Detail
Back